Table 3.

Comparison of counting data between metastatic and non-metastatic patients in the training set

Variable	Total	LNM group (n=80)	Non-LNM group (n=348)	Statistic	P
Age
<45	189	36	153	0.028	0.867
≥45	239	44	195
BMI
<24 kg/m2	151	24	127	1.201	0.273
≥24 kg/m2	277	56	221
Disease type
Squamous cell carcinoma	380	69	311	1.707	0.426
Adenocarcinoma	43	9	34
Others	5	2	3
Tumor size
<2 cm	203	29	174	9.758	0.008
2-4 cm	199	41	158
>4 cm	26	10	16
FIGO grading
IB1	181	24	157	15.523	0.001
IB2	157	27	130
IB3	26	10	16
IIA1	64	19	45
Differentiation degree
Well differentiated	160	20	140	8.343	0.015
Moderately differentiated	164	41	123
Poorly differentiated	104	19	85
Lymphovascular invasion
Without	89	26	63	8.185	0.004
With	339	54	285
History of hypertension
Without	72	10	62	1.314	0.252
With	356	70	286
History of diabetes
Without	51	6	45	1.828	0.176
With	377	74	303

Note: LNM, Lymph node metastasis; BMI, body mass index; FIGO, International Federation of Obstetrics and Gynecology.